CARDAX (CDXI) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 1 12 sessions, August 15, 2025 to August 27, 2026
- Largest daily move
- -97.5% close of September 24, 2025
- 1-year change
- -97.5% closing prices, August 15, 2025 to August 27, 2026
Company Description
CARDAX (OTC: CDXI) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $80.0.
CDXI has declined 97.5% over the past year. The last closing price was $0.0001.
This page collects what Stock Titan holds for CDXI, including price data and latest news.
Stock Performance
CARDAX (CDXI) closed at $0.0001 on August 27, 2026. Over the past 12 months, the price has lost 97.5%.
CDXI Metrics & Rankings
Price returns through August 27, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
CARDAX has 4 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 1 with negative movement. Key topics include earnings. View all CDXI news →
SEC Filings
CDXI Company Profile & Sector Positioning
CARDAX (CDXI) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing CDXI often look at related companies in the same sector, including REBUS HLDGS INC (RBSH), AMPIO PHARMS INC (AMPE), ONCOLOGY PHARMA INC (ONPH), KALEIDO BIOSCIENCES INC (KLDO), and BETTER THERAPEUTICS INC (BTTX). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CDXI's relative position within its industry.